Rory B. Riggs - May 27, 2021 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role
Director
Signature
/s/ Lawrence J. Hineline, Attorney-in-fact
Stock symbol
ITCI
Transactions as of
May 27, 2021
Transactions value $
$0
Form type
4
Date filed
6/4/2021, 04:05 PM
Previous filing
May 28, 2021
Next filing
Jun 8, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITCI Common Stock Options Exercise +13.8K +22.23% 75.7K May 27, 2021 Direct F1
holding ITCI Common Stock 227K May 27, 2021 Held by New Ventures I, LLC F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITCI Restricted Stock Units Options Exercise $0 -13.8K -100% $0.00* 0 May 27, 2021 Common Stock 13.8K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Mr. Riggs is Managing Member of New Ventures I, LLC and may be deemed to beneficially own the securities held by New Ventures I, LLC. Mr. Riggs disclaims beneficial ownership of the securities held by New Ventures I, LLC except to the extent of his pecuniary interest therein.
F3 On May 27, 2020, the reporting person was granted 13,767 restricted stock units, vesting on the first anniversary of the grant date (May 27, 2021).